Literature DB >> 12466116

Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice.

Chundong Yu1, Fen Wang, Chengliu Jin, Xiaochong Wu, Wai-kin Chan, Wallace L McKeehan.   

Abstract

Carbon tetrachloride (CCl(4)) intoxification in rodents is a commonly used model of both acute and chronic liver injury. Recently, we showed that mice in which FGFR4 was ablated from the germline exhibited elevated cholesterol metabolism and bile acid synthesis coincident with unrepressed levels of cytochrome P450 7A (CYP7A), the rate-limiting enzyme in cholesterol disposal. Of the four fibroblast growth factor (FGF) receptor genes expressed in adult liver, FGFR4 is expressed specifically in mature hepatocytes. To determine whether FGFR4 plays a broader role in liver-specific metabolic functions, we examined the impact of both acute and chronic exposure to CCl(4) in FGFR4-deficient mice. Following acute CCl(4) exposure, the FGFR4-deficient mice exhibited accelerated liver injury, a significant increase in liver mass and delayed hepatolobular repair. Chronic CCl(4) exposure resulted in severe fibrosis in livers of FGFR4-deficient mice compared to normal mice. Analysis at both mRNA and protein levels indicated an 8-hour delay in FGFR4-deficient mice in the down-regulation of cytochrome P450 2E1 (CYP2E1) protein, the major enzyme whose products underlie CCl(4)-induced injury. These results show that hepatocyte FGFR4 protects against acute and chronic insult to the liver and prevents accompanying fibrosis. The results show that FGFR4 acts by promotion of processes that restore hepatolobular architecture rather than cellularity while limiting damage due to prolonged CYP2E1 activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466116      PMCID: PMC1850898          DOI: 10.1016/S0002-9440(10)64478-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Plasminogen activators direct reorganization of the liver lobule after acute injury.

Authors:  J A Bezerra; A R Currier; H Melin-Aldana; G Sabla; T H Bugge; K W Kombrinck; J L Degen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Involvement of protein kinase A in fibroblast growth factor-2-activated transcription.

Authors:  J P Pursiheimo; M Jalkanen; K Taskén; P Jaakkola
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Plasminogen deficiency leads to impaired remodeling after a toxic injury to the liver.

Authors:  J A Bezerra; T H Bugge; H Melin-Aldana; G Sabla; K W Kombrinck; D P Witte; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4.

Authors:  C Yu; F Wang; M Kan; C Jin; R B Jones; M Weinstein; C X Deng; W L McKeehan
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

5.  Increased carbon tetrachloride hepatotoxicity, and its mechanism, after chronic ethanol consumption.

Authors:  Y Hasumura; R Teschke; C S Lieber
Journal:  Gastroenterology       Date:  1974-03       Impact factor: 22.682

6.  Plasminogen deficiency results in poor clearance of non-fibrin matrix and persistent activation of hepatic stellate cells after an acute injury.

Authors:  V L Ng; G E Sabla; H Melin-Aldana; N Kelley-Loughnane; J L Degen; J A Bezerra
Journal:  J Hepatol       Date:  2001-12       Impact factor: 25.083

7.  Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury.

Authors:  J F Pohl; H Melin-Aldana; G Sabla; J L Degen; J A Bezerra
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

8.  Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase.

Authors:  M Kan; X Wu; F Wang; W L McKeehan
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

9.  Mitogen-activated protein kinase and protein kinase A signaling pathways stimulate cholecystokinin transcription via activation of cyclic adenosine 3',5'-monophosphate response element-binding protein.

Authors:  T V Hansen; J F Rehfeld; F C Nielsen
Journal:  Mol Endocrinol       Date:  1999-03

Review 10.  Fibroblast growth factors.

Authors:  D M Ornitz; N Itoh
Journal:  Genome Biol       Date:  2001-03-09       Impact factor: 13.583

View more
  37 in total

1.  Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway.

Authors:  Po Zhao; Giuseppina Caretti; Stephanie Mitchell; Wallace L McKeehan; Adele L Boskey; Lauren M Pachman; Vittorio Sartorelli; Eric P Hoffman
Journal:  J Biol Chem       Date:  2005-11-02       Impact factor: 5.157

2.  SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolism.

Authors:  Tenghui Chen; Qiang Chen; Yixiang Xu; Qiling Zhou; Jingwei Zhu; Hao Zhang; Qiao Wu; Jianming Xu; Chundong Yu
Journal:  J Hepatol       Date:  2011-08-07       Impact factor: 25.083

3.  Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.

Authors:  Doaa A Ghareeb; Hani S Hafez; Hend M Hussien; Nihal F Kabapy
Journal:  Metab Brain Dis       Date:  2011-09-01       Impact factor: 3.584

Review 4.  FGFR4: A promising therapeutic target for breast cancer and other solid tumors.

Authors:  Kevin M Levine; Kai Ding; Lyuqin Chen; Steffi Oesterreich
Journal:  Pharmacol Ther       Date:  2020-05-31       Impact factor: 12.310

5.  FXR regulates liver repair after CCl4-induced toxic injury.

Authors:  Zhipeng Meng; Yandong Wang; Lin Wang; Wen Jin; Nian Liu; Hao Pan; Lucy Liu; Lawrence Wagman; Barry M Forman; Wendong Huang
Journal:  Mol Endocrinol       Date:  2010-03-08

6.  The protective role of Per2 against carbon tetrachloride-induced hepatotoxicity.

Authors:  Peng Chen; Chunying Li; Wenqaing Pang; Yue Zhao; Wei Dong; Shiming Wang; Jianfa Zhang
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

7.  The Role of PPARα Activation in Liver and Muscle.

Authors:  Lena Burri; G Hege Thoresen; Rolf K Berge
Journal:  PPAR Res       Date:  2010-08-18       Impact factor: 4.964

8.  Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.

Authors:  Saurav Singh; Alexander Grabner; Christopher Yanucil; Karla Schramm; Brian Czaya; Stefanie Krick; Mark J Czaja; Rene Bartz; Reimar Abraham; Giovana S Di Marco; Marcus Brand; Myles Wolf; Christian Faul
Journal:  Kidney Int       Date:  2016-07-22       Impact factor: 10.612

9.  Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.

Authors:  Chundong Yu; Fen Wang; Chengliu Jin; Xinqiang Huang; David L Miller; Claudio Basilico; Wallace L McKeehan
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.

Authors:  Kwang-Hoon Song; Tiangang Li; Erika Owsley; Stephen Strom; John Y L Chiang
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.